Biodistribution and Toxicological Safety of Adenovirus Type 5 and Type 35 Vectored Vaccines Against Human Immunodeficiency Virus-1 (HIV-1), Ebola, or Marburg Are Similar Despite Differing Adenovirus Serotype Vector, Manufacturer's Construct, or Gene Inserts-Reference-Cited by-同舟云学术

Biodistribution and Toxicological Safety of Adenovirus Type 5 and Type 35 Vectored Vaccines Against Human Immunodeficiency Virus-1 (HIV-1), Ebola, or Marburg Are Similar Despite Differing Adenovirus Serotype Vector, Manufacturer's Construct, or Gene Inserts

Published:2008-01 Issue:3 Volume:5 Page:315-335
ISSN:1547-691X
Container-title:Journal of Immunotoxicology
language:en
Short-container-title:Journal of Immunotoxicology

Author:

Sheets Rebecca L.¹,Stein Judith¹,Bailer Robert T.¹,Koup Richard A.¹,Andrews Charla¹,Nason Martha²,He Bin³,Koo Edward³,Trotter Holly⁴,Duffy Chris⁴,Manetz T.⁵,Gomez Phillip⁶

Affiliation:

1. Vaccine Research Center, NIH/NIAID, Bethesda, Maryland, USA

2. Biostatistics Research Branch, NIH/NIAID, Bethesda, Maryland, USA

3. Bridge Laboratories, Gaithersburg, Maryland, USA

4. Althea Technologies, Inc., San Diego, California, USA

5. MedImmune, Inc., Gaithersburg, Maryland, USA

6. PRTM, Washington, DC, USA

Publisher

Informa UK Limited

Subject

Toxicology,Immunology

Link